|Title:||Methods for the treatment of cancer|
|Abstract:||A pharmaceutical composition comprising an effective cancerous cell growth inhibiting amount of paclitaxel, or a paclitaxel derivative, and an effective cancerous cell growth inhibiting amount of an active agent which inhibits cancerous cell growth by exerting an effect on mammalian cell cycle during G.sub.1 or S-phase of the cell division cycle to inhibit said cancerous cell growth and methods of using same.|
|Inventor(s):||Vande Woude; George F. (Berryville, VA), Schulz; Nicholas (Pittsburgh, PA), Zhou; Renping (Frederick, MD), Daar; Ira (Frederick, MD), Oskarsson; Marianne (Gaitherburg, MD)|
|Assignee:||The United States of America as represented by the Department of Health and Human Services (Washington, DC)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|World Intellectual Property Organization (WIPO)||9219765||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.